Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK
- DOI
- 10.1007/s40290-022-00439-7
- Published
- 2022-07-28
- Container
- Pharmaceutical Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s40290-022-00439-7,
title = {Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK},
author = {Rajmeet Jandu and Carl Naraynassamy and Nadarajah Sreeharan},
year = {2022},
journal = {Pharmaceutical Medicine},
doi = {10.1007/s40290-022-00439-7},
url = {https://doi.org/10.1007/s40290-022-00439-7}
}RIS
TY - JOUR TI - Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK AU - Rajmeet Jandu AU - Carl Naraynassamy AU - Nadarajah Sreeharan PY - 2022 JO - Pharmaceutical Medicine DO - 10.1007/s40290-022-00439-7 UR - https://doi.org/10.1007/s40290-022-00439-7 ER -
APA
Jandu, R., Naraynassamy, C., & Sreeharan, N. (2022). Are the Current Processes and Regulations Fit for Purpose to Deliver Novel Therapies During Pandemics? A Perspective on COVID-19 from the UK. Pharmaceutical Medicine. https://doi.org/10.1007/s40290-022-00439-7
Source records
- crossref · retrieved 2026-09-26T19:39:55.188Z